Overview

Magnesium Sulphate in the Ultrasound-guided Supraclavicular Brachial Plexus Block

Status:
Completed

Trial end date:
2019-03-01

Target enrollment:
0

Participant gender:
All

Summary

This study evaluated the motor and sensory block duration and the postoperative analgesic effects of adding Magnesium Sulphate to bupivacaine in the ultrasound-guided supraclavicular brachial plexus block Anesthesia. Motor and sensory block duration were considered as a primary endpoint.

Phase:

Phase 2

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

Magrabi Eye & Ear Hospital

Treatments:

Bupivacaine
Magnesium Sulfate

Criteria

Inclusion Criteria:

1. - ASA physical status I to II,

2. - Patients listed for elective forearm or hand surgery using supraclavicular brachial
plexus block anesthesia

Exclusion Criteria:

1 - evidence of severe cardiovascular, renal, or hepatic diseases, preexisting neurological
or psychiatric illnesses.

2- patients have allergy to the study drugs. 3 - patients who have any contraindications to
brachial plexus block anesthesia.

4- pregnant or lactating women, or 5- if the BMI was > 35 kg/m2.